Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy

The COVID-19 pandemic has led to a rise in cases of Guillain-Barré syndrome (GBS). This autoimmune sequela is a manifestation of the neurotropism potential of the virus. At present, knowledge regarding the pathophysiology, clinical features, management and outcomes of the condition is still evolving...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Jao Jarro, Turalde, Christian Wilson, Bagnas, Marjorie Anne, Anlacan, Veeda Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118003/
https://www.ncbi.nlm.nih.gov/pubmed/33975846
http://dx.doi.org/10.1136/bcr-2021-242365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118003/
https://www.ncbi.nlm.nih.gov/pubmed/33975846
http://dx.doi.org/10.1136/bcr-2021-242365

Ejemplares similares